The divestiture of fipronil and other fungicides was required by the U.S. Federal Trade Commission and European Commission as part of Bayer CropScience’s acquisition Aventis CropScience. The planned divestiture was announced in late October and negotiations between Bayer ES and BASF finally wrapped up after the European Commission approved the deal March 24.
Retaining rights to market the Chipco products in the turf and ornamental market gives Bayer ES a solid insecticide lineup.
“It is a very strong product line and it gives us a good strong position in South with fire ant control and mole cricket control,” said Jim Fetter, director of marketing for Bayer ES. “We are clearly the leader in terms of insecticides and this helps us maintain our strong leadership position there. These products are new, patented, proprietary products and are rapidly growing because they have been introduced within the last five years. They are on a strong growth curve.”
The deal ends months of speculation about how the back-license of fipronil products would be structured.
“There was negotiation going on,” Fetter said. “It has been up in the air because it is a complicated deal. You have to work out all the details about which assets go, which plants are included and all that kind of stuff. It has taken time to work out the details.”
Explore the May 2003 Issue
Check out more from this issue and find your next story to read.